News

Categories
  1. Pediatric leukemia

    FDA approves Tasigna (nilotinib) for certain pediatric patients with Ph+ CML in chronic phase.
    Industry news

    Read more »
  2. Diabetic retinopathy

    FDA approves Genentech’s Lucentis (ranibizumab injection) syringe for diabetic macular edema and diabetic retinopathy.

    FDA

    Read more »
  3. Leukemia

    CLL expert explains latest treatment developments in the field.
    leukemia

    Read more »
  4. Lymphoma

    FDA expands approval of Adcetris (brentuximab vedotin) for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy.
    Industry news

    Read more »
  5. Prostate cancer

    Expert emphasises healthy lifestyle in prostate cancer care.
    Industry news

    Read more »
  6. HIV/AIDS

    The FDA has approved a new HIV treatment for patients with limited treatment options.
    HIV AIDS

    Read more »
  7. Leukemia

    Kymriah, the first FDA-approved CAR-T cell therapy, is showing promising results in treating children with acute lymphoblastic leukemia.
    leukemia

    Read more »
  8. Breast cancer

    The Food and Drug Administration (FDA) have extended the approval of Verzenio (abemaciclib) to now be a first line treatment for some types of advanced or metastatic breast cancer.
    breast cancer

    Read more »
  9. Thyroid cancer

    The UK institute NICE gives 3 nods in thyroid cancer: Cometriq (cabozantinib), Nexavar (sorafenib) and Lenvima (lenvatinib).
    thyroid cancer

    Read more »
  10. Parkinson’s disease

    FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions. 
    parkinson's disease

    Read more »
  11. Lung cancer

    Imfinzi (durvalumab), already approved for some bladder cancers, is now FDA approved for some patients with lung cancer.
    Industry news

    Read more »
  12. New prices negotiated! Reductions for 38 products

    Price decreases for 38 medicines

    Read more »
  13. Leukemia

    In a recent trial, 80% of patients with (MRD)-positive acute lymphoblastic leukemia (ALL) who were treated with a drug called Blincyto (blinatumomab) achieved a complete response.
    Industry news

    Read more »
  14. Prostate cancer

    The FDA has approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread, but that continues to grow despite treatment with hormone therapy.
    Industry news

    Read more »
  15. MS

    The Scottish Medicines Consortium (SMC) has approved Mavenclad (cladribine) as a treatment for highly active relapsing multiple sclerosis.
    Industry news

    Read more »
  16. Oncology

    Scientists experimenting with an innovative treatment for cancer have now devised a targeted injection that has already successfully eliminated tumours in mice.
    Industry news

    Read more »
  17. Immunotherapy

    The first ever patient to be treated with a new type of CAR-T cell therapy in a novel clinical trial is now in remission.
    Industry news

    Read more »
  18. New microneedle product could help people with ALS, MS and diabetes

    Remember the hypospray from Star Trek? Maybe it's close to reality.

    Star Trek magazine cover

    Read more »
  19. Breast cancer

    A new combination of medicines is showing positive results in ER/HER2-Positive breast cancer.
    Industry news

    Read more »
  20. Autism

    The experimental drug from Roche (balovaptan) has now been given Breakthrough Therapy Designation, potentially placing the drug on a faster path to market as the first pharmacological treatment for autism spectrum disorder (ASD). Pharmatimes, 30/01/2018.
    Industry news

    Read more »
  21. Digestive tract cancer

    Following the EMA’s approval in late 2017, the FDA has now also approved Lutathera (lutetium Lu 177 dotatate) for certain digestive tract cancers.
    Industry news

    Read more »
  22. What are the latest breakthroughs in multiple sclerosis (MS)?

    The potential of neuroprotective agents for a whole new form of treatment.

    MS

    Read more »
  23. New medicines coming soon!

    A list of medicines TheSocialMedwork will soon be making available.

    New medicines

    Read more »
  24. Ovarian cancer

    New test detects ovarian and 7 other cancers using simple blood sample.
    Industry news

    Read more »
  25. Lymphoma

    Brentuximab vedotin (Adcetris) has now been approved by the European Commission for the treatment of patients with CD30-positive cutaneous T-cell lymphoma (CTCL) who have had at least 1 prior systemic therapy.
    Industry news

    Read more »
  26. Breast cancer

    Lynparza (olaparib) is the first PARP inhibitor approved to treat breast cancer, and the first medicine ever for metastatic breast cancer who have a “BRCA” gene mutation.
    Industry news

    Read more »
  27. Multiple sclerosis

    Ocrevus (ocrelizumab), the first ever FDA approved medicine for primary progressive MS has now also been approved by the EMA.
    Industry news

    Read more »
  28. Kidney cancer

    A new study found that cabozantinib (Cabometyx) was more effective than everolimus in advanced renal cell carcinoma and bone metastases.
    kidney cancer

    Read more »
  29. Esophageal cancer

    Pembrolizumab showed positive results in heavily pretreated, PD-L1–positive advanced esophageal carcinoma.
    Industry news

    Read more »
  30. Melanoma

    Specific strains of intestinal bacteria can improve the response rate to immunotherapy for patients being treated for advanced melanoma.
    Industry news

    Read more »
CA